These and 3 other cell lines that have been generously donated from other researchers are being used to screen 1000 drugs / compounds with the aim of finding a treatment for this disease. Some of these drugs are already used in the treatment of other tumours, some of which are in development.
Dr Tim Forshew has recently joined UCL Cancer Institute using his expertise to measure small amounts of the DNA thrown out of the tumour into the blood stream. With Professor Flanagan he is trying to develop a blood test to monitor patients with this tumour. This is important as the disease recurs in many patients and the sooner that this can be detected the better for the patient. Chordoma UK has donated £20,000.00 ($34,000.00) towards the equipment (a digital PCR machine).
Access to chordoma samples is critical for research into this disease: However, access to chordoma samples is a rate limiting step in research, this is particularly the case as it is such a rare disease, occurring in only 1 in 800,000 of the population. If you have had a chordoma removed in the past, or if you are about to have a chordoma surgery in the future, it would be most valuable - indeed essential for the research team to have access to some of your tumour. Researchers would only use the sample if it were surplus to clinical/diagnostic requirements, and if there was the appropriate ethical approval and consent. Professor Flanagan’s goal is to create a collection of 500 chordoma samples to undertake the analysis of the DNA in these samples. Alterations in the DNA is what makes tumours grow in an uncontrolled manner. Such a large scale study will provide useful information about what makes chordoma grow, and this may lead to ideas about how new treatments for the disease could be developed.
If you would like more information we can arrange for you to be put in contact with Professor Flanagan’s team. You can find the Patient Information Sheet and the Consent Form on the Royal National Orthopaedic Hospital’s Website.You can also contact the team here.